CarThera: Funding, Investors & Team (Sep 2026)
Since its inception, CarThera has been dedicated to designing and creating groundbreaking medical devices that utilize ultrasound therapy to treat various brain disorders. One of the company's exclusive products, known as SonoCloud®, is an implant that utilizes ultrasound technology to temporarily open the blood-brain barrier (BBB), thereby enabling a remarkable increase in the delivery of therapeutic molecules to the brain.
CarThera has raised $56.3M across 3 funding rounds on record, the most recent a Series B of $4.8M announced in Dec 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CarThera Company Profile and Key Stats
Latest funding round on record: Dec 2023.
CarThera Funding Rounds
CarThera raised $10.5M in an undisclosed round announced in Sep 2020.
2.8 years later, a Series B of $41.0M was announced in Jun 2023.
6 months later, a Series B of $4.8M was announced in Dec 2023.
CarThera Founders and Leadership Team
Contact details for the CarThera team: 1 of 2 have an email address on file.
Start 14-day free trial →CarThera Funding Compared to Other Biotechnology Startups
CarThera's latest round of $4.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CarThera in Biotechnology and Paris
Companies Similar to CarThera
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
CarThera Funding FAQs
What does CarThera do?
Since its inception, CarThera has been dedicated to designing and creating groundbreaking medical devices that utilize ultrasound therapy to treat various brain disorders. One of the company's exclusive products, known as SonoCloud®, is an implant that utilizes ultrasound technology to temporarily open the blood-brain barrier (BBB), thereby enabling a remarkable increase in the delivery of therapeutic molecules to the brain.
How much funding has CarThera raised?
CarThera has raised $56.3M across 3 rounds on record. The most recent is a Series B of $4.8M announced in Dec 2023.
When did CarThera last raise funding?
CarThera's most recent funding round on record is a Series B of $4.8M, announced in Dec 2023.
Who founded CarThera?
FundedIQ lists Alexandre Carpentier (Founder) at CarThera.
Who is the CEO of CarThera?
Frederic Sottilini is listed as CEO at CarThera.
Where is CarThera headquartered?
CarThera is based in Paris, Ile-De-France, France.
How many employees does CarThera have?
CarThera is in the 11-50 employee band.
How does CarThera's funding compare to other Biotechnology startups?
CarThera's latest round of $4.8M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's CarThera Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CarThera is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.